Department of Hepato-Pancreato-Biliary and Transplant Surgery, Hospital Universitari Vall D'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Can J Gastroenterol Hepatol. 2021 Mar 22;2021:6643595. doi: 10.1155/2021/6643595. eCollection 2021.
Changes in BUN have been proposed as a risk factor for complications in acute pancreatitis (AP). Our study aimed to compare changes in BUN versus the Bedside Index for Severity in Acute Pancreatitis (BISAP) score and the Acute Physiology and Chronic Health Evaluation-II score (APACHE-II), as well as other laboratory tests such as haematocrit and its variations over 24 h and C-reactive protein, in order to determine the most accurate test for predicting mortality and severity outcomes in AP.
Clinical data of 410 AP patients, prospectively enrolled for study at our institution, were analyzed. We define AP according to Atlanta classification (AC) 2012. The laboratory test's predictive accuracy was measured using area-under-the-curve receiver-operating characteristics (AUC) analysis and sensitivity and specificity tests.
Rise in BUN was the only score related to mortality on the multivariate analysis (=0.000, OR: 12.7; CI 95%: 4.2-16.6). On the comparative analysis of AUC, the rise in BUN was an accurate test in predicting mortality (AUC: 0.842) and persisting multiorgan failure (AUC: 0.828), similar to the BISAP score (AUC: 0.836 and 0.850) and APACHE-II (AUC: 0.756 and 0.741). The BISAP score outperformed both APACHE-II and rise in BUN at 24 hours in predicting severe AP (AUC: 0.873 vs. 0.761 and 0.756, respectively).
Rise in BUN at 24 hours is a quick and reliable test in predicting mortality and persisting multiorgan failure in AP patients.
血尿素氮 (BUN) 的变化已被提出作为急性胰腺炎 (AP) 并发症的危险因素。我们的研究旨在比较 BUN 变化与床边急性胰腺炎严重程度指数 (BISAP) 评分和急性生理学和慢性健康评估-Ⅱ评分 (APACHE-Ⅱ) 的变化,以及其他实验室检查,如红细胞比容及其 24 小时变化和 C 反应蛋白,以确定预测 AP 死亡率和严重程度结局最准确的检查。
对我院前瞻性纳入的 410 例 AP 患者的临床资料进行分析。我们根据亚特兰大分类 (AC) 2012 定义 AP。使用曲线下面积接收器操作特性 (AUC) 分析和敏感性和特异性测试来测量实验室测试的预测准确性。
BUN 升高是多变量分析中唯一与死亡率相关的评分 (=0.000,OR:12.7;95%CI:4.2-16.6)。在 AUC 的比较分析中,BUN 的升高是预测死亡率 (AUC:0.842) 和持续多器官衰竭 (AUC:0.828) 的准确测试,与 BISAP 评分 (AUC:0.836 和 0.850) 和 APACHE-Ⅱ (AUC:0.756 和 0.741) 相似。BISAP 评分在预测重度 AP 方面优于 APACHE-Ⅱ和 24 小时 BUN 升高 (AUC:0.873 与 0.761 和 0.756 相比)。
24 小时 BUN 升高是预测 AP 患者死亡率和持续多器官衰竭的快速可靠的检查。